Celgene Corporation reported IPR&D impairments of $69,156,000 for the fourth quarter ended December 31, 2012.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
108.2 USD | +0.10% |
|
-1.97% | +68.89% |
- Stock Market
- Equities
- CELG Stock
- News Celgene
- Celgene Corporation Reports IPR&D Impairments for the Fourth Quarter Ended December 31, 2012